Active, not recruitingNot applicableNCT04774445
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Studying Genetic Susceptibility to Cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Principal Investigator
- Angela R Bradbury, MDUniversity of Pennsylvania
- Intervention
- MyCancerGene(behavioral)
- Enrollment
- 400 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Collaborators
American Cancer Society, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04774445 on ClinicalTrials.govOther trials for Genetic Susceptibility to Cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT05350761Rare Tumors and Cancer Predisposition in Individuals and FamiliesNational Cancer Institute (NCI)
- ENROLLING BY INVITATIONNCT06584994Investigating the Role of Genetics in Disease PredispositionThe Wellcome Sanger Institute
- RECRUITINGNCT04903782Cancer Predisposition Testing by Family-based Whole-genome Sequencing (WGS) in Every Child With Newly Diagnosed CancerSydney Children's Hospitals Network
- RECRUITINGNANCT04141462EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset CancerCentre Georges Francois Leclerc
- RECRUITINGNCT04265937ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTiesFudan University
- ACTIVE NOT RECRUITINGNCT00001163Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of CancerNational Cancer Institute (NCI)